Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,144.14
(
-1.16%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 87700

Thursday, 12/17/2009 5:42:02 PM

Thursday, December 17, 2009 5:42:02 PM

Post# of 257579
PYMX MNTA:

why couldn't PMX-60056 theoretically be partnered with SNY or, better yet, Sandoz/MNTA?

The commercial benefit of having reversibility data would accrue not only to branded Lovenox, but also to any substitutable generic and vice-versa. Hence, if SNY or NVS sponsored a PMX-60056 program, they would be helping their competitor as much as they would be helping themselves.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today